Skip to main content
Fig. 1 | BMC Medical Imaging

Fig. 1

From: Roles of contrast-enhanced ultrasonography in identifying volume change of benign thyroid nodule and optical time of secondary radiofrequency ablation

Fig. 1

Preoperative and postoperative ultrasonography of one patient. A: preoperative ultrasonography (A1: longitudinal section of two-dimensional ultrasonography; A2: transverse section of two-dimensional ultrasonography); B: postoperative ultrasonography at 0 months (A1: longitudinal section of contrast-enhanced ultrasonography; A2: longitudinal section of two-dimensional ultrasonography; A3: transverse section of contrast-enhanced ultrasonography; A4: transverse section of two-dimensional ultrasonography); C: postoperative ultrasonography at 1 months (C1: longitudinal section of contrast-enhanced ultrasonography; C2: longitudinal section of two-dimensional ultrasonography; C3: transverse section of contrast-enhanced ultrasonography; C4: transverse section of two-dimensional ultrasonography); D: postoperative ultrasonography at 3 months (D1: longitudinal section of contrast-enhanced ultrasonography; D2: longitudinal section of two-dimensional ultrasonography; D3: transverse section of contrast-enhanced ultrasonography; D4: transverse section of two-dimensional ultrasonography); E: postoperative ultrasonography at 6 months (E1: longitudinal section of contrast-enhanced ultrasonography; E2: longitudinal section of two-dimensional ultrasonography; E3: transverse section of contrast-enhanced ultrasonography; E4: transverse section of two-dimensional ultrasonography); F: postoperative ultrasonography at 12 months (F1: longitudinal section of contrast-enhanced ultrasonography; F2: longitudinal section of two-dimensional ultrasonography; F3: transverse section of contrast-enhanced ultrasonography; F4: transverse section of two-dimensional ultrasonography)

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us